Foghorn Therapeutics (FHTX) Profit After Tax (2020 - 2025)
Historic Profit After Tax for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to -$15.8 million.
- Foghorn Therapeutics' Profit After Tax rose 1711.64% to -$15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.1 million, marking a year-over-year increase of 2093.88%. This contributed to the annual value of -$86.6 million for FY2024, which is 1199.48% up from last year.
- Foghorn Therapeutics' Profit After Tax amounted to -$15.8 million in Q3 2025, which was up 1711.64% from -$17.9 million recorded in Q2 2025.
- In the past 5 years, Foghorn Therapeutics' Profit After Tax ranged from a high of -$14.3 million in Q3 2023 and a low of -$30.5 million during Q1 2023
- Over the past 5 years, Foghorn Therapeutics' median Profit After Tax value was -$24.1 million (recorded in 2023), while the average stood at -$23.6 million.
- Per our database at Business Quant, Foghorn Therapeutics' Profit After Tax tumbled by 6485.09% in 2021 and then skyrocketed by 4433.23% in 2023.
- Foghorn Therapeutics' Profit After Tax (Quarter) stood at -$29.1 million in 2021, then grew by 0.76% to -$28.9 million in 2022, then rose by 16.59% to -$24.1 million in 2023, then increased by 19.09% to -$19.5 million in 2024, then rose by 18.74% to -$15.8 million in 2025.
- Its last three reported values are -$15.8 million in Q3 2025, -$17.9 million for Q2 2025, and -$18.8 million during Q1 2025.